SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-031561
Filing Date
2024-06-27
Accepted
2024-06-27 16:06:56
Documents
13
Period of Report
2024-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ef20031807_8k.htm   iXBRL 8-K 38006
  Complete submission text file 0001140361-24-031561.txt   174720

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kron-20240625.xsd EX-101.SCH 3868
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kron-20240625_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kron-20240625_pre.xml EX-101.PRE 16046
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20031807_8k_htm.xml XML 4227
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 241079191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)